Eagle Rock Investment Company’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,985
Closed -$2.34M 159
2026
Q1
$2.34M Sell
7,985
-23
-0.3% -$7.56K 0.34% 68
2025
Q4
$2.81M Sell
8,008
-384
-5% -$130K 0.4% 61
2025
Q3
$2.71M Sell
8,392
-166
-2% -$51.6K 0.4% 62
2025
Q2
$3.33M Buy
8,558
+355
+4% +$143K 0.53% 53
2025
Q1
$3.57M Buy
8,203
+1,281
+19% +$514K 0.61% 46
2024
Q4
$2.55M Sell
6,922
-7,147
-51% -$2.99M 0.42% 66
2024
Q3
$7.32M Buy
14,069
+2,826
+25% +$1.51M 1.23% 23
2024
Q2
$6.09M Sell
11,243
-335
-3% -$177K 1.1% 26
2024
Q1
$6M Buy
11,578
+406
+4% +$202K 1.11% 25
2023
Q4
$5.27M Buy
11,172
+7
+0.1% +$3.24K 1.08% 24
2023
Q3
$4.86M Buy
11,165
+402
+4% +$182K 1.1% 28
2023
Q2
$4.71M Buy
10,763
+403
+4% +$186K 1.01% 31
2023
Q1
$4.76M Buy
10,360
+1,266
+14% +$602K 1.09% 29
2022
Q4
$4.37M Buy
9,094
+297
+3% +$151K 1.01% 31
2022
Q3
$4M Buy
8,797
+3,509
+66% +$1.68M 1.04% 32
2022
Q2
$2.55M Buy
5,288
+1,124
+27% +$556K 0.62% 45
2022
Q1
$2.04M Buy
+4,164
New +$1.9M 0.43% 53

Other funds holding ELV

Eagle Rock Investment Company's ELV Position: Q2 2026 in Review

Eagle Rock Investment Company sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 7,985 shares — an estimated $2.34M sold.

Eagle Rock Investment Company first reported a position in ELV in Q1 2022 and held it in 17 quarters. The position peaked at $7.32M in Q3 2024. 565 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Eagle Rock Investment Company reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Eagle Rock Investment Company sold 7,985 Elevance Health shares in Q2 2026, an estimated $2.34M.
  • Eagle Rock Investment Company first reported a position in Elevance Health in Q1 2022 and held it in 17 quarters.
  • Eagle Rock Investment Company's Elevance Health position peaked at $7.32M in Q3 2024.
  • 565 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Eagle Rock Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.